Age, GH/IGF-1 levels, tumor volume, T2 hypointensity, and tumor subtype rather than proliferation and invasion are all reliable predictors of biochemical response to somatostatin analogue therapy in patients with acromegaly: A clinicopathological study
Autor: | Durmuş, Elif Tutku, Atmaca, Ayşegül, Kefeli, Mehmet, Çalışkan, Sultan, Mete, Ozgur, Aslan, Kerim, Fidan, Murat, Çolak, Ramis, Durmuş, Buğra |
---|---|
Zdroj: | In Growth Hormone & IGF Research December 2022 67 |
Databáze: | ScienceDirect |
Externí odkaz: |